13F Pro

SEC Form 4 reporting owner

Turner Christopher Durant

Turner Christopher Durant has filed 18 Form 4 transactions reported between January 5, 2026 and July 15, 2026, as Chief Medical Officer of Nuvalent, Inc..

Name as filed: Turner Christopher Durant

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$721K
7 lines
Companies
1
with Form 4 filings
Latest transaction
Jul 15, 2026
transaction date

Roles and reported holdings

  • NUVLNuvalent, Inc.
    Jan 5, 2026 – Jul 15, 2026

    Chief Medical Officer

    Held directly55,130 sh as of Jan 6, 2026 · Form 4

    24 months: $721K sold

Transaction history

All 18 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jul 15, 2026NUVLChief Medical OfficerDisposition to issuerCode D · direct17,500—Form 4
Jul 15, 2026NUVLChief Medical OfficerDisposition to issuerCode D · direct37,500—Form 4
Jul 15, 2026NUVLChief Medical OfficerDisposition to issuerCode D · direct47,500—Form 4
Jul 15, 2026NUVLChief Medical OfficerDisposition to issuerCode D · direct144,200—Form 4
Jul 15, 2026NUVLChief Medical OfficerDisposition to issuerCode D · direct107,000—Form 4
Jul 15, 2026NUVLChief Medical OfficerDisposition to issuerCode D · direct2,835—Form 4
Jul 15, 2026NUVLChief Medical OfficerDisposition to issuerCode D · direct303,105—Form 4
Jul 15, 2026NUVLChief Medical OfficerGrant or awardCode A · direct14,350—Form 4
Jul 15, 2026NUVLChief Medical OfficerDisposition to issuerCode D · direct41,100—Form 4
Jul 15, 2026NUVLChief Medical OfficerTender in change of controlCode U · direct31,530$3.9M@ $124.00Form 4
Jan 7, 2026NUVLChief Medical OfficerGrant or awardCode A · direct17,500—Form 4
Jan 6, 2026NUVLChief Medical OfficerOpen-market saleCode S · directAlso reported by Noci Darlene, Balcom Alexandra225$22K@ $98.40Form 4
Jan 6, 2026NUVLChief Medical OfficerOpen-market saleCode S · directAlso reported by Noci Darlene, Balcom Alexandra1,635$159K@ $97.33Form 4
Jan 6, 2026NUVLChief Medical OfficerOpen-market saleCode S · directAlso reported by Noci Darlene, Balcom Alexandra1,321$128K@ $96.75Form 4
Jan 5, 2026NUVLChief Medical OfficerOpen-market saleCode S · directAlso reported by Noci Darlene, Balcom Alexandra317$31K@ $98.52Form 4
Jan 5, 2026NUVLChief Medical OfficerOpen-market saleCode S · directAlso reported by Noci Darlene, Balcom Alexandra1,929$189K@ $97.96Form 4
Jan 5, 2026NUVLChief Medical OfficerOpen-market saleCode S · directAlso reported by Noci Darlene, Balcom Alexandra1,119$108K@ $96.85Form 4
Jan 5, 2026NUVLChief Medical OfficerOpen-market saleCode S · directAlso reported by Noci Darlene, Balcom Alexandra871$84K@ $96.06Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.